Literature DB >> 2912937

Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation.

G M Tozer1, Z M Bhujwalla, J R Griffiths, R J Maxwell.   

Abstract

Phosphorus-31 magnetic resonance spectra were obtained from the RIF-1 tumor in C3H mice before and up to 2 days after various doses of X rays. Parallel studies were performed to measure relative changes in tumor blood perfusion using [14C]iodo-antipyrine and changes in % tumor necrosis using Chalkley's method. Tumor ratios of phosphocreatine to inorganic phosphate (PCr/Pi) and nucleotide triphosphates to inorganic phosphate (NTP/Pi) as well as pH as measured by 31P-MRS increased significantly at most time points after irradiation with doses of 5, 10, and 20 Gy. Tumor blood perfusion was found to significantly improve after a dose of 20 Gy but not after a dose of 2 Gy. Percent tumor necrosis increased to about 3 times its control level at 1 day after a dose of 20 Gy and then declined to about twice its control value at 2 days. The magnitude of the changes in the 31P-MRS parameters makes it unlikely that any of them are entirely due to radiation-induced changes in the radiobiologically hypoxic fraction of these tumors. Changes in the necrotic fraction did not appear to influence the tumor spectra. However, the observed improvement in tumor blood perfusion may have resulted in an increase in oxidative phosphorylation of the whole tumor population as well as a clearance of inorganic phosphate and acid metabolites, so that 31P-MRS changes may indirectly reflect changes in tumor blood perfusion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912937     DOI: 10.1016/0360-3016(89)90023-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  15 in total

Review 1.  Applications of magnetic resonance in model systems: tumor biology and physiology.

Authors:  R J Gillies; Z M Bhujwalla; J Evelhoch; M Garwood; M Neeman; S P Robinson; C H Sotak; B Van Der Sanden
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.

Authors:  Barjor Gimi; Arvind P Pathak; Ellen Ackerstaff; Kristine Glunde; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2005-04-01       Impact factor: 10.961

3.  Dual-energy micro-computed tomography imaging of radiation-induced vascular changes in primary mouse sarcomas.

Authors:  Everett J Moding; Darin P Clark; Yi Qi; Yifan Li; Yan Ma; Ketan Ghaghada; G Allan Johnson; David G Kirsch; Cristian T Badea
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-01       Impact factor: 7.038

Review 4.  Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors?

Authors:  Sergey V Kozin; Dan G Duda; Lance L Munn; Rakesh K Jain
Journal:  J Natl Cancer Inst       Date:  2012-05-09       Impact factor: 13.506

5.  31P-NMR spectroscopy and histological studies of the response of rat mammary tumours to endocrine therapy.

Authors:  M Stubbs; R C Coombes; J R Griffiths; R J Maxwell; L M Rodrigues; B A Gusterson
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

6.  Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension.

Authors:  G M Tozer; R J Maxwell; J R Griffiths; P Pham
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

7.  Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRS.

Authors:  S Baluch; C J Midwood; J R Griffiths; M Stubbs; R C Coombes
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

8.  MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.

Authors:  Mounia Beloueche-Babari; Slawomir Wantuch; Teresa Casals Galobart; Markella Koniordou; Harold G Parkes; Vaitha Arunan; Yuen-Li Chung; Thomas R Eykyn; Paul D Smith; Martin O Leach
Journal:  Cancer Res       Date:  2017-09-18       Impact factor: 12.701

9.  Stable bioenergetic status despite substantial changes in blood flow and tissue oxygenation in a rat tumour.

Authors:  P Vaupel; D K Kelleher; T Engel
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

10.  The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours.

Authors:  I A Burney; R J Maxwell; J R Griffiths; S B Field
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.